S
Stockadora

Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 4753 Reports
🤖 AI Analyzed
Recent
📄 Page 286 of 397
Passage BIO, Inc.
10-K March 3, 2026

Key Highlights

  • Passage BIO is a genetic medicines company focused on developing gene therapies ...
  • The company leverages scientific expertise and proprietary technologies to addre...
  • Maintained strategic collaborations with Gemma Biotherapeutics Inc. and the Univ...
Read Analysis
🤖 AI Generated
RYTHM, Inc.
10-K March 3, 2026

Key Highlights

  • Successful strategic pivot from capital-intensive equipment to the growing hemp-...
  • Established brand portfolio including RYTHM, Señorita, incredibles, and Beboe, w...
  • Secured partnerships with major retailers like Total Wine, ABC Fine Wine & Spiri...
Read Analysis
🤖 AI Generated
Blue Owl Credit Income Corp.
10-K March 3, 2026

Key Highlights

  • Focuses on senior secured lending to U.S. middle-market companies for steady inc...
  • Leverages a strong affiliation with Blue Owl Capital Inc., providing access to e...
  • Maintains a robust and diversified capital structure, utilizing both debt and eq...
Read Analysis
🤖 AI Generated
Quantum-Si Inc
10-K March 3, 2026

Key Highlights

  • Quantum-Si is commercializing a groundbreaking single-molecule protein sequencin...
  • Reported initial revenues of $12.5 million in 2025, with strong projected growth...
  • Concluded fiscal year 2025 with a strong cash position of $155.8 million, provid...
Read Analysis
🤖 AI Generated
Fortitude Gold Corp
10-K March 3, 2026

Key Highlights

  • Achieved strong financial results in 2025 with $69.8 million revenue, $18.5 mill...
  • Maintained a robust financial position with $25.4 million in cash and zero long-...
  • Isabella Pearl Mine consistently produced 35,500 ounces of gold and 52,000 ounce...
Read Analysis
🤖 AI Generated
Paysafe Ltd
20-F March 3, 2026

Key Highlights

  • Paysafe generated $236.2 million in positive operating cash flow in 2025 despite...
  • The company ended 2025 with $250.2 million in cash and cash equivalents, a 15.5%...
  • Paysafe's Board authorized an additional $70 million in share repurchases, signa...
Read Analysis
🤖 AI Generated
SOPHiA GENETICS SA
20-F March 3, 2026

Key Highlights

  • Achieved strong revenue growth of approximately 25% year-over-year to an estimat...
  • Flagship SOPHiA DDM™ platform utilizes AI to analyze over 1.2 million genomic pr...
  • Secured strategic partnerships with major pharmaceutical companies, launched new...
Read Analysis
🤖 AI Generated
North Haven Private Income Fund LLC
10-K March 3, 2026

Key Highlights

  • Operates as a direct lender, primarily investing in floating-rate debt instrumen...
  • Floating-rate strategy benefits from rising interest rates, potentially offering...
  • Maintained healthy profitability and consistent income generation, driven by a d...
Read Analysis
🤖 AI Generated
Cellebrite DI Ltd.
20-F March 3, 2026

Key Highlights

  • Cellebrite reported strong financial performance in 2025 with $350 million in re...
  • Strategic acquisitions of CyberTechnology (July 2024) and Corellium (December 20...
  • The company maintains a strong competitive position as a market leader in Digita...
Read Analysis
🤖 AI Generated
On Holding AG
20-F March 3, 2026

Key Highlights

  • Exceptional financial performance with revenue surging over 40% and net income g...
  • Strong D2C channel growth of over 50%, now accounting for approximately 35% of t...
  • Optimistic future outlook projecting continued revenue growth in the high 20s to...
Read Analysis
🤖 AI Generated
Blue Owl Technology Income Corp.
10-K March 3, 2026

Key Highlights

  • Delivered solid financial performance with a 12% increase in Net Investment Inco...
  • Declared and paid $1.70 per share in dividends, representing an approximate 11.5...
  • Maintained strong portfolio quality with non-accrual investments at only 0.5% of...
Read Analysis
🤖 AI Generated
Prime Medicine, Inc.
10-K March 3, 2026

Key Highlights

  • Developing Prime Editing, a revolutionary gene editing technology for precise ge...
  • Initiated Phase 1/2 clinical trials for lead program PMO-101 in Q4 2023, with in...
  • Maintained a robust financial position with $520 million in cash, cash equivalen...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage